–
Unicycive Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.98
FY22:
−18.1
FY23:
−20.8
FY24:
−32.1
FY25:
−29.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.96
FY22:
−17.9
FY23:
−19.9
FY24:
−30.4
FY25:
−27.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.0
FY22:
−18.1
FY23:
−30.5
FY24:
−36.7
FY25:
−26.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.0
FY22:
−18.1
FY23:
−30.5
FY24:
−36.7
FY25:
−26.6
All amounts in millions USD